Osteoarthritis

Adherence to stepped care for the management of knee osteoarthritis in the Netherlands

Osteoarthritis CartilagePublished Prospective cohort study

Authors' conclusion

Despite clinical guidelines outlining a SC approach to manage knee OA, only a small proportion of patients of 55 years of age or older with knee complaints have utilized all non-surgical treatment options before being referred for orthopedic consultation in the Netherlands. Most patients consulting an orthopedic surgeon receive conservative treatment modalities, also included in the Dutch clinical guideline on knee symptoms for GPs.

Study context

Population
Patients aged ≥55 years with a symptomatic knee before orthopedic consultation, three hospitals, the Netherlands (mean age 66.8 years, 54% female)
Participants
7,874 patients
Exposure
Full Stepped Care (SC) vs partial SC vs no SC adherence before orthopedic consultation
Outcome
SC adherence prior to orthopedic consultation
Methodological detailsmulticentre (three hospitals), regression analyses
  • Multicentre (three hospitals)
  • Regression analyses

Main finding

As reported in the abstract

Observational data: associations, not effects.

Further findings

Factors associated with arthroplasty as treatment choice

OR (95% CI)
Longer symptom durationHighest OR4.4 (3.7–5.3)

Non-operative OA management following orthopedic consultation

Proportion of patients receiving non-operative OA management
71.6%

Factors associated with arthroplasty as treatment choice

Increasing age, higher BMI, longer symptom duration, greater pain during activity, reduced walking ability and full SC adherence all associated with higher odds of arthroplasty

Original publication

Adherence to stepped care for the management of knee osteoarthritis in the Netherlands. Osteoarthritis Cartilage. Published 4 September 2026. doi:10.1016/j.joca.2026.08.014

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.